Levetiracetam Injection USP – LYVOS 500 Injection
Composition – Levetiracetam 100 mg/ml
The composition Levetiracetam Injection USP contains Levetiracetam, a novel anticonvulsant agent that provides broad-spectrum efficacy in managing epilepsy. It works by binding to synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and stabilizing synaptic transmission. Additionally, it inhibits calcium influx in N-type calcium channels, controlling neuronal excitability. This dual mechanism helps control seizures and associated symptoms like jerking movements, confusion, and loss of awareness, making it highly effective in acute and chronic settings.
KEY BENEFITS:
1. Broad Spectrum Seizure Management: Effective in partial-onset, myoclonic, and generalized tonic- clonic seizures.
2. Superior Tolerability: Reduced risk of sedation, cognitive side effects, and drug interactions, making it suitable for patients with comorbidities or on multiple medications.
3. Rapid Action : Injectable form ensures swift seizure control in critical or emergency situations
Targeted Specalists:
Neurologists
Disclaimer:
To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion










